ATE47522T1 - Antiparasitaere nichtwaessrige formulierung ein avermektin oder milbemycin enthaltend. - Google Patents
Antiparasitaere nichtwaessrige formulierung ein avermektin oder milbemycin enthaltend.Info
- Publication number
- ATE47522T1 ATE47522T1 AT84309044T AT84309044T ATE47522T1 AT E47522 T1 ATE47522 T1 AT E47522T1 AT 84309044 T AT84309044 T AT 84309044T AT 84309044 T AT84309044 T AT 84309044T AT E47522 T1 ATE47522 T1 AT E47522T1
- Authority
- AT
- Austria
- Prior art keywords
- avermectin
- milbemycin
- antiparastic
- formulation containing
- aqueous formulation
- Prior art date
Links
- 239000005660 Abamectin Substances 0.000 title abstract 2
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 title abstract 2
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 title abstract 2
- 239000013011 aqueous formulation Substances 0.000 title 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 abstract 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 abstract 1
- 208000030852 Parasitic disease Diseases 0.000 abstract 1
- 239000003096 antiparasitic agent Substances 0.000 abstract 1
- 229940125687 antiparasitic agent Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 229940074076 glycerol formal Drugs 0.000 abstract 1
- 229960002418 ivermectin Drugs 0.000 abstract 1
- 239000012669 liquid formulation Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 238000001228 spectrum Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56414083A | 1983-12-22 | 1983-12-22 | |
| EP84309044A EP0146414B1 (de) | 1983-12-22 | 1984-12-21 | Antiparasitäre nichtwässrige Formulierung ein Avermektin oder Milbemycin enthaltend |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE47522T1 true ATE47522T1 (de) | 1989-11-15 |
Family
ID=24253315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT84309044T ATE47522T1 (de) | 1983-12-22 | 1984-12-21 | Antiparasitaere nichtwaessrige formulierung ein avermektin oder milbemycin enthaltend. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0146414B1 (de) |
| JP (1) | JPH0623100B2 (de) |
| KR (1) | KR880002366B1 (de) |
| AT (1) | ATE47522T1 (de) |
| AU (1) | AU560864B2 (de) |
| CA (1) | CA1267844A (de) |
| DE (1) | DE3480263D1 (de) |
| DK (1) | DK164772C (de) |
| ES (1) | ES8608888A1 (de) |
| GR (1) | GR81244B (de) |
| HK (1) | HK5091A (de) |
| IE (1) | IE57681B1 (de) |
| IL (1) | IL73800A (de) |
| NZ (1) | NZ210505A (de) |
| PT (1) | PT79656B (de) |
| SG (1) | SG97890G (de) |
| ZA (1) | ZA849841B (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3883408T2 (de) * | 1987-01-23 | 1993-12-09 | Pfizer | Verfahren zur Herstellung von Avermectinen und die verwendeten Kulturen. |
| US5075307A (en) * | 1987-07-28 | 1991-12-24 | Merck & Co., Inc. | Paraherquamide and dihydroparaherquamide as antihelminthic agents |
| GB8803836D0 (en) * | 1988-02-18 | 1988-03-16 | Glaxo Group Ltd | Compositions |
| US6001822A (en) * | 1989-04-11 | 1999-12-14 | Pfizer Inc. | Antiparasitic formulations |
| US5169846A (en) * | 1989-10-12 | 1992-12-08 | Crooks Michael J | Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators |
| NZ335166A (en) | 1999-04-14 | 2001-11-30 | Ashmont Holdings Ltd | Anthelmintic composition containing triclabendazole in at least one solvent |
| GB2275193A (en) * | 1993-02-17 | 1994-08-24 | Merck & Co Inc | Formulations for the topical delivery of avermectins |
| PL174488B1 (pl) * | 1993-05-10 | 1998-08-31 | Merck & Co Inc | Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt |
| PT697814E (pt) * | 1993-05-10 | 2003-11-28 | Merck & Co Inc | Formulacoes para verter que contem material polimerico glicois e gliceridos |
| US5602107A (en) * | 1993-05-10 | 1997-02-11 | Merck & Co., Inc. | Pour-on formulations consisting of gylcols, glycerides and avermectin compounds |
| DE19613972A1 (de) * | 1996-04-09 | 1997-10-16 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl |
| DE19638045A1 (de) * | 1996-09-18 | 1998-03-19 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen |
| ZA981925B (en) * | 1997-03-21 | 1998-10-23 | Biogenesis S A | A long acting injectable parasiticidal composition and the process for its preparation |
| AR013202A1 (es) * | 1997-07-10 | 2000-12-13 | Biotech Australia Pty Ltd | Vacunas no acuosas |
| GB9816132D0 (en) * | 1998-07-24 | 1998-09-23 | Norbrook Lab Ltd | Non-aqueous anthelmintic composition |
| WO2001020994A1 (en) * | 1999-09-22 | 2001-03-29 | Ashmont Holdings Limited | Sheep pour-on |
| JP2001253824A (ja) * | 2000-03-14 | 2001-09-18 | Mitsukazu Matsumoto | 局所注射用処方剤 |
| GR1003969B (el) * | 2001-02-05 | 2002-08-14 | U��-Pharma ����� ������ ������������ ���������� ���� | Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης. |
| US20050009762A1 (en) | 2003-06-06 | 2005-01-13 | Strobel Michael Albert | Application of water and organic solvent soluble ivermectin for topical and oral use |
| US6627613B2 (en) | 2001-07-23 | 2003-09-30 | Michael A. Strobel | Application of water and organic solvent soluble ivermectin for topical and oral use |
| GB2386066A (en) | 2002-02-28 | 2003-09-10 | Norbrook Lab Ltd | Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species |
| UY27412A1 (es) * | 2002-08-12 | 2003-06-30 | Carlson Internat Inc | Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn. |
| GB0316377D0 (en) | 2003-07-12 | 2003-08-13 | Norbrook Lab Ltd | Parasiticidal composition |
| JP4886214B2 (ja) * | 2005-05-24 | 2012-02-29 | 日本パワーファスニング株式会社 | 石膏ボード締結用の2条式木ねじ |
| WO2010042395A1 (en) | 2008-10-08 | 2010-04-15 | Wyeth Llc | Benzimidazole anthelmintic compositions |
| JP5607114B2 (ja) | 2012-06-26 | 2014-10-15 | 株式会社トープラ | タッピンねじ |
| JP2024516912A (ja) | 2021-05-14 | 2024-04-17 | シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト | 昆虫、ダニ目及び線虫有害生物の防除 |
| WO2022268815A1 (en) | 2021-06-24 | 2022-12-29 | Syngenta Crop Protection Ag | Insect, acarina and nematode pest control |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4144352A (en) * | 1977-12-19 | 1979-03-13 | Merck & Co., Inc. | Milbemycin compounds as anthelmintic agents |
| US4130651A (en) * | 1978-03-31 | 1978-12-19 | American Cyanamid Company | Butamisole injectable formulations having improved margin of safety in dogs |
| NZ197796A (en) * | 1980-08-04 | 1984-11-09 | Merck & Co Inc | Stabilised aqueous formulations containing ivermectin |
| US4430329A (en) * | 1982-05-17 | 1984-02-07 | Merck & Co., Inc. | Synergistic treatment of adult canine heartworm with thiacetarsamide and ivermectin |
-
1984
- 1984-12-10 NZ NZ210505A patent/NZ210505A/xx unknown
- 1984-12-11 PT PT79656A patent/PT79656B/pt unknown
- 1984-12-11 IL IL73800A patent/IL73800A/xx not_active IP Right Cessation
- 1984-12-12 GR GR81244A patent/GR81244B/el unknown
- 1984-12-14 IE IE3221/84A patent/IE57681B1/en not_active IP Right Cessation
- 1984-12-14 CA CA000470213A patent/CA1267844A/en not_active Expired - Lifetime
- 1984-12-18 ZA ZA849841A patent/ZA849841B/xx unknown
- 1984-12-18 ES ES538750A patent/ES8608888A1/es not_active Expired
- 1984-12-20 JP JP59267598A patent/JPH0623100B2/ja not_active Expired - Lifetime
- 1984-12-21 EP EP84309044A patent/EP0146414B1/de not_active Expired
- 1984-12-21 DK DK619784A patent/DK164772C/da active
- 1984-12-21 AU AU37024/84A patent/AU560864B2/en not_active Expired
- 1984-12-21 DE DE8484309044T patent/DE3480263D1/de not_active Expired
- 1984-12-21 AT AT84309044T patent/ATE47522T1/de not_active IP Right Cessation
- 1984-12-21 KR KR1019840008224A patent/KR880002366B1/ko not_active Expired
-
1990
- 1990-12-10 SG SG978/90A patent/SG97890G/en unknown
-
1991
- 1991-01-10 HK HK50/91A patent/HK5091A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK5091A (en) | 1991-01-18 |
| IE843221L (en) | 1985-06-22 |
| DE3480263D1 (en) | 1989-11-30 |
| EP0146414A2 (de) | 1985-06-26 |
| DK619784D0 (da) | 1984-12-21 |
| IE57681B1 (en) | 1993-02-24 |
| AU3702484A (en) | 1985-07-04 |
| DK619784A (da) | 1985-06-23 |
| IL73800A (en) | 1987-11-30 |
| ES538750A0 (es) | 1986-07-16 |
| CA1267844A (en) | 1990-04-17 |
| EP0146414B1 (de) | 1989-10-25 |
| KR850004391A (ko) | 1985-07-15 |
| GR81244B (en) | 1985-04-16 |
| ES8608888A1 (es) | 1986-07-16 |
| IL73800A0 (en) | 1985-03-31 |
| PT79656B (en) | 1987-01-16 |
| DK164772C (da) | 1993-01-04 |
| EP0146414A3 (en) | 1986-12-10 |
| JPS60169415A (ja) | 1985-09-02 |
| SG97890G (en) | 1991-02-14 |
| NZ210505A (en) | 1988-06-30 |
| DK164772B (da) | 1992-08-17 |
| KR880002366B1 (ko) | 1988-11-03 |
| JPH0623100B2 (ja) | 1994-03-30 |
| PT79656A (en) | 1985-01-01 |
| ZA849841B (en) | 1986-07-30 |
| AU560864B2 (en) | 1987-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE47522T1 (de) | Antiparasitaere nichtwaessrige formulierung ein avermektin oder milbemycin enthaltend. | |
| SE8402551D0 (sv) | Cinnamoylmoranolin-derivat | |
| IT1173705B (it) | Formulazione farmaceutica di clometacina per somministrazione orale e procedimento di preparazione | |
| DE69725745D1 (de) | Injizierbare zusammensetzungen | |
| ES547737A0 (es) | Un dispositivo medico para la administracion transdermal de un agente biologicamente activo. | |
| ES8607721A1 (es) | Un procedimiento para la solubilizacion y estabilizacion de un agente antiparasitario. | |
| IT1128094B (it) | Catetere per la somministrazione en dovenosa intermittente di medicamenti | |
| SE8406538D0 (sv) | Novel derivatives of purine | |
| NO831610L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oxicamderivater. | |
| ES284914Y (es) | Dispositivo para la administracion percutanea de un principio activo. | |
| NO168648C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive nitrogenholdige derivater av epipodofyllotoksin-glukosidderivater. | |
| IE810891L (en) | Topical formulation | |
| GB2008944A (en) | Copper compositions for topical application in the treatment of copper deficiency in animals | |
| ES2040774T3 (es) | Procedimiento para la preparacion de una formulacion medicamentosa. | |
| NO167573C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive (5r, 6s,)-6-((r)-1-hydroksyetyl)-2-azacykloalkyltio-2-penem-3-karboksyl-syrederivater. | |
| NO160142C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive (1,2,4)triazolo(4,3-a)kinoksalin-4-amin-derivater. | |
| NO159590C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive fenyleddiksyre-derivater. | |
| SE7904840L (sv) | Antiviralt verksamma t-rna-preparat | |
| GB2162746A (en) | Antiacidotic medicinal agent | |
| AR224526Q (es) | Derivados de s-fenoxi o feniltioalquil-n,n-dialquil-tiolcarbamatos y composiciones herbicidas,germicidas y acaricidas que los contienen como agente activo | |
| FI863940L (fi) | Foerfarande foer utbredning av stycketorv/granulat pao ett faelt medelst en maskin med en matrisplatta. | |
| IT8619218A0 (it) | Procedimento per la preparazione di 3,5-diammino-1,2,4-triazolo derivati. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |